Nontuberculous mycobacterial (NTM) infection in HIV (human immunodeficiency virus)-infected patients who have started highly active antiretroviral therapy (HAART) is well known to be one scenario of immune reconstitution inflammatory syndrome (IRIS). We encountered the first case in Japan of an HIV-infected patient with pulmonary Mycobacterium parascrofulaceum infection as IRIS. A 34 year-old man with acquired immunodeficiency syndrome (AIDS) was receiving highly active antiretroviral therapy. Lymphadenopathy was observed at the left pulmonary hilum. IRIS was suspected and thoracoscopic surgery was performed to diagnose the cause of lymphadenopathy. Granulomas were observed histologically, and M. parascrofulaceum was cultured. This organism was susceptible to Clarithromycin, rifampicin and levofloxacin. After the operation and without treatment, recurrence of M. parascrofulaceum infection was not observed. M. parascrofulaceum was isolated from several clinical specimens for the first time in 2004. To date, only five cases have been reported.
Introduction
Nontuberculous mycobacterial (NTM) infection in HIVinfected patients who have started highly active antiretroviral therapy (HAART) is well known to be one scenario of immune reconstitution inflammatory syndrome (IRIS). M. parascrofulaceum infection was first reported in 2004 (1) . There has been little information about M. parascrofulaceum infection or therapies for treating this organism. We encountered a case of pulmonary M. parascrofulaceum infection in an HIV-infected patient, and describe the clinical features of M. parascrofulaceum infection. In addition, since it was possible to culture M. parascrofulaceum, the results of the drug sensitivity test are also reported.
F i g u r e 1 . Ga l l i u m a c c u mu l a t i o n a t t h e l e f t h i l u m ( Da y 3 2 a f t e r HAART ) . Ar r o ws : Ga l l i u m a c c u mu l a t i o n a t t h e l e f t h i l u m.

T a b l e 1 . L a b o r a t o r y F i n d i n g s o n Ad mi s s i o n
In January 2009, highly active anti-retroviral therapy (HAART), raltegravir (RAL) + stavudine (d4T) + lamivudine (3TC), was started. HAART was effective and the counts of CD4 increased to 42/μL. The HIV-RNA load decreased to 300 copies/mL in February 2009. Although there were no certain symptoms, IRIS was suspected because the CD4 count was low so a gallium scan to monitor the total body was needed in February 2009. Positive accumulation of gallium was observed at the left hilum (Fig. 1) . A chest CT scan revealed lymphadenopathy in the left hilum region where there was a low density area, suggesting a necrotic lesion within it. Then, the size of lymphadenopathy enlarged from 11 mm in diameter to 22 mm. As the cause of lymphadenopathy infection, M. tuberculosis, NTM, Cryptococcus or Nocardia lymphadenopathy was suspected (Fig. 2) . HIV-infected patients might develop disseminated disease
F i g u r e 2 . L y mp h a d e n o p a t h y wh i c h c o n t a i n e d a l o w d e n s i t y a r e a r a p i d l y e n l a r g e d , p a r a l l e l i n g t h e i n c r e a s e o f CD4 . Gr o u n d -g l a s s o p a c i t y ( GGO) i s s e e n n e a r t h e l y mp h a d e n o p a t h y .
F i g u r e 3 . A: S e c t i o n o f s e g me n t 5 o b t a i n e d b y t h o r a c o s c o p y . S ma l l n o d u l a r n e c r o s e s a r e d e t e c te d . B : Ac i d -f a s t b a c i l l i a r e s e e n i n t h e n e c r o t i c l y mp h a d e n o p a t h y ( Z i e h l -Ne e l s e n s t a i n , × 1 0 0 0 ) . C: Hi s t o l o g y o f t h e l u n g . T h e r e a r e c a p s u l a t e d e p i t h e l i o i d c e l l g r a n u l o ma s wi t h c a s e o u s n e c r o s i s a n d g i a n t c e l l s a r o u n d t h e g r a n u l o ma ( He ma t o x y l i n a n d E o s i n s t a i n i n g , × 1 0 0 ) . D: E p i t h e l i o i d c e l l , c a s eo u s n e c r o s i s , a n d g i a n t c e l l s a r e o b s e r v e d ( He ma t o x y l i n a n d E o s i n s t a i n i n g , × 2 0 0 ) .
T a b l e 2 . Mi n i mu m I n h i b i t o r y Co n c e n t r a t i o n T a b l e 3 . Re v i e w o f P a s t Ca s e Re p o r t s
due to M. avium complex (MAC) or NTM, but this case had negative blood cultures indicating that this infection was a localized lesion. To diagnose the cause of lymphadenopathy, thoracoscopic surgery was performed and acid-fast bacilli were confirmed by the fluorescent staining. A part of left lung segment 5, which showed atelectasis, was also resected. Macroscopically, the resected lung showed atelectasis with a small nodular necrosis (Fig. 3A) . Pathological findings demonstrated that the lymphadenopathy contained necrotic material and epithelioid cells. In addition, a ZiehlNeelsen stain of the lymph node demonstrated acid-fast bacilli (Fig. 3B) . In the lung, tissue sections were stained with Hematoxylin and Eosin (HE), and capsulated epithelioid cell granuloma with caseous necrosis and Langhans-type giant cells around granuloma were observed (Fig. 3C, D) . Based on these findings, the cause of lymphadenopathy was diagnosed to be IRIS of mycobacterial infection.
PCR for M. tuberculosis and MAC and DNA-DNA hybridization (DDH) assay could not identify the pathogen of the IRIS. Then, 16S rRNA assay (2), rpoB assay (3), and hsp65 sequence analysis (4) were performed. M. fortuitum, M. parascrofulaceum, M. saskatchewanense and Mycobacterium sp. were nominated by the 16SrRNA assay. A database was not available for the rpoB. Hsp65 sequence analysis was in accordence with M. parascrofulaceum (99%) but denied M. fortuitum. The hsp65 sequence of M. saskatchewanense showed that the rate of concordance was low (96%), and therefore, M. saskatchewanense was denied. Finally, this organism was considered to be M. parascrofulaceum. Antimicrobial susceptibility test showed that this organism was susceptible to clarithromycin, rifampicin and levofloxacin ( Table 2) .
Ten-months after the operation, there has been no recurrence of M. parascrofulaceum infection and chemotherapy has not been administered.
Discussion
M. parascrofulaceum is classified as Group II by the Runyon classification because this organism is scotochromogenic and slow growing (1, 5) . Genotypically, the organism is most closely related to M. simiae. However, it presents a similar phenotypic profile to M. scrofulaceum (1) . Growth was observed from 25 to 37 , and optimum growth was observed at 37 (1).
Environmental mycobacteria are normal inhabitants of a wide variety of habitats, including natural and municipal water and soil (6) . Their high innate resistance to chlorine and biocides in the water distribution system and their capacities for biofilm formation can explain their prevalence, and M. parascrofulaceum also has similar characteristics. M. parascrofulaceum has another characteristic in that it can grow in acidic condition and high temperature 56 , and can be found in the acidic hot springs of Yellowstone National Park (6) . Thus, the infection route of M. parascrofulaceum was thought to be a hot spring or municipal water and soil.
M. parascrofulaceum was first termed by Turenne et al in 2004 and five cases have been reported up to date (Table 3 ). All five cases had underlying diseases: one was old tuberculosis, two were AIDS, another was malignancy and the fifth was bronchiectasis (1, 7) . In fact, M. parascrofulaceum is an opportunistic pathogen, like many other nontuberculous mycobacterial species (1). Turenne et al suggested that rifampicin, clarithromycin, amikacin, linezolid and moxifloxacin are effective. However, to date, the outcome of M. parascrofulaceum infection was unclear and most of the reported cases died of infection. In the present study, it was suggested that rifampicin, clarithromycin and levofloxacin were effective in accordance with the previous report (1), and rifampicin, clarithromycin and new quinolones were the key drugs for this organism.
Because, the pathologic lesion of the lung and lymph node were clearly resected, and with HAART his immunity was strengthened sufficiently to overcome M. parascrofulaceum, therefore it was not necessary to use chemotherapy. That was the different compared to the past cases.
Cases of M. parascrofulaceum have been few. Our case report discusses the clinical course, methods for organism identification, susceptibility testing, and treatment.
